AI Drug Developer

Pharmaceutical Research, Manufacturing, and Packaging Companies
On February 6, 2024, MindRank, which focuses on using AI-driven new drug R&D, announced,Completed the key phased delivery of the collaboration project on the knowledge graph with MSD China.

This project is based on the "MindRank" biopharmaceutical knowledge graph PharmKG™ platform, combined with self-developedMedical Insight™ AI Large Model Technology,Dedicated to building a more efficient knowledge graph for pharmaceutical R&D information insights.
About MindRank
MindRank is a clinical-stage AI-driven innovative drug discovery company. The company’s vision is to continuously deliver differentiated and high clinical value drug candidates by promoting the integration of various cutting-edge technologies in artificial intelligence and new drug research and development, thereby helping more lives regain health.
The AI pharmaceutical solution of the company was rated as one of the "11 most important AI drug R&D breakthrough achievements globally from 2018 to 2020" by the authoritative European and American institution Deep Pharma Intelligence. In 2023, it was selected for Forbes' "Forbes Asia 100 to Watch" list, with only 11 start-up companies from mainland China making the list.
For more information, please visit the website: www.mindrank.ai
Cooperation: bd@mindrank.ai
Other: info@mindrank.ai
